Debra Zack
No más puestos en curso
Fortuna: 174 135 $ al 31/03/2024
Perfil
Debra Jeske Zack worked as an Executive Director-Global Product Area at Amgen, Inc. and as a Vice President-Clinical Development at Xencor, Inc. Prior to that, she was an Associate Professor at the University of California, Los Angeles.
She also served as the Chief Medical Officer at Exagen, Inc. from 2020 to 2022.
Dr. Zack received her undergraduate degree from Texas Christian University and her doctorate from The University of Texas Southwestern Medical Center.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EXAGEN, INC.
0.64% | 18/04/2023 | 109 519 ( 0.64% ) | 174 135 $ | 31/03/2024 |
Antiguos cargos conocidos de Debra Zack.
| Empresas | Cargo | Fin |
|---|---|---|
| EXAGEN INC. | Chief Tech/Sci/R&D Officer | 05/12/2022 |
| University of California, Los Angeles | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
| XENCOR, INC. | Corporate Officer/Principal | - |
Formación de Debra Zack.
| Texas Christian University | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| EXAGEN INC. | Health Services |
- Bolsa de valores
- Insiders
- Debra Zack
